New Grants Added This Week – 19th January 2025 to 26th January 2025
There were 58 new schemes added last week with a total amount available of £1,000,000.
The amounts available range from £1,000,000 to £1,000,000.
Money is available for the following funding purposes: Business Innovation, Purchasing Equipment and Recruit and Develop Staff.
Money is available for the following business types: Academic, Medium Business, Micro Business, Research Organisation and Small Business.
Top 10 Funding Opportunities:
Small-Scale Hydrogen Valley
The project funded under this topic should contribute to outcomes including, but not limited to, anchorage of new demand for renewable hydrogen and interaction and synergies among initial test beds and full integration into the broader cross-sectoral energy ecosystem.
Large-Scale Hydrogen Valley
The project funded under this topic should contribute to outcomes including, but not limited to, anchorage of new demand for renewable hydrogen, interaction and synergies among initial test beds and full integration into the broader cross-sectoral energy ecosystem.
Per- and Poly-Fluoroalkyl Substance (PFAS) Exposure, Emissions, and End of Life Management in the Healthcare Sector
The action funded under this topic is expected to achieve impacts including, but not limited to, contributing to IHI JU SRIA objectives, driving cross-sectoral health innovation for a competitive European health industry and contributing to the objectives of the Industrial Strategy for Europe and Pharmaceutical Strategy for Europe.
Global Collaboration Action for the Development of Vaccines for Reducing the Disease Burden of Tuberculosis in Sub-Saharan Africa
This topic aims to fund actions that will contribute to increased international cooperation among researchers and funders, catalyse research synergies, and leverage resources and investments in order to achieve the reduction of disease burden in SSA through the development of vaccines.
Accelerating the Development of Prophylactic Vaccines Against Neglected Tropical Diseases (NTDs) in Sub-Saharan Africa
This topic aims to support activities that contribute to one or more of the expected impacts for this call. These include generating data on novel or existing vaccines to make progress towards prevention, control and elimination of NTDs in SSA, improving the understanding of barriers for progression of new or improved vaccines against NTDs through the R&D pipeline and generating clinical data including pregnant and lactating women, new-borns, children, adolescents, other vulnerable and neglected populations, and people with co-infections and co-morbidities at risk in SSA as relevant.
Boosting Innovation Through Better Integration of Fragmented Health R&I Efforts
The actions to be funded under this topic are expected to achieve impacts including, but not limited to, breaking down fragmentation between various disciplines of medicine and technological areas in order to conceive and develop technologically and socially innovative, people-centred, integrated healthcare solutions that can seamlessly be introduced in healthcare systems.
Boosting Innovation through Exploitation of Digitalisation and Data Exchange in Healthcare
The actions to be funded under this topic are expected to achieve impacts including, but not limited to, wider availability of interoperable, quality data, respecting FAIR (findable, accessible, interoperable, reusable) principles, facilitating research and the development of integrated products and services.
Global Collaboration Action for Research on Existing Malaria Therapeutics and Clinical Development of New Antimalarial Candidates
This topic aims to fund actions that will contribute to increased international cooperation among researchers and funders, catalyse research synergies, and leverage resources and investments in order to achieve rapid advances in the development of new or improved anti-malarial drugs or drug combinations.
Boosting Innovation for Better Assessment of the Added Value of Innovative Integrated Healthcare Solutions
The actions to be funded under this topic are expected to achieve impacts including, but not limited to, seamless and successful implementation in healthcare settings of cross-sectoral innovations, integrated products and services delivering proven benefits to patients, healthcare systems and society as a whole.
Improved Lifetime and Cost of High-Temperature Electrolysers by Introducing Innovative Materials and Components in Stacks and BoP
The projects funded under this topic should contribute to outcomes including, but not limited to, improvements to already conceptualised novel materials including electrocatalysts, electrodes, metallic interconnects, coatings, and seals enabling increased lifetime to the ensemble of both single cells and stacks.